Pseudomona Aeruginosa: A Challenge for Intensive Care Units

Evelin Noriega Campos

doi:doi:10.11648/j.ajhr.20210905.11

| Peer-Reviewed

Pseudomona Aeruginosa: A Challenge for Intensive Care Units

Evelin Noriega Campos

Published in American Journal of Health Research (Volume 9, Issue 5)

Received: 21 July 2021 Accepted: 30 July 2021 Published: 4 September 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Introduction: Pseudomonas Aeruginosa is one of the main gram-negative germs that cause nosocomial infections, very frequent in intensive care units, with an increase in antimicrobial resistance in recent years. The World Health Organization (WHO) expressed the existence of a problem that threatens modern medicine: bacterial resistance together with infections associated with healthcare. Objectives: to carry out a bibliographic review on the incidence of Pseudomonas Aeruginosa in intensive care units and its presence as a causal agent of coinfection in patients with COVID-19. Methods: a search of articles was carried out in internet search engines in Spanish and English such as: Pubmed, Medline, Academic Google, Dialnet; of articles published in the last ten years in Spanish or English, the term Pseudomonas Aeruginosa was used as the only descriptor in intensive care units, COVID-19. Conclusions: in almost all patients with nosocomial infections, mainly those with pneumonia associated with mechanical ventilation, the common denominator is the isolation of Pseudomona Aeruginosa in at least one of the cultures performed. This situation is maintained as a problem to be solved that shows greater complexity in the context of the current pandemic. Is necessary to establish new cross infection control measures and analyze other therapeutic alternatives if one takes into account that resistance has been increasing in recent years.

Published in	American Journal of Health Research (Volume 9, Issue 5)
DOI	10.11648/j.ajhr.20210905.11
Page(s)	112-116
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Pseudomona Aeruginosa, Nosocomial Infection, Intensive Care Unit

References

[1]	Nathan C, Cars O. Antibiotic Resistance-Problems, Progress, and Prospects. N Engl J Med [Internet] 2014 [Accessed 04/21/2021]; 371 (19): 1761–3. Available at: https://pubmed.ncbi.nlm.nih.gov/25271470/.
[2]	Hernández A, Yagüe G, GarcíaVázquez E, Simón M, Parrado Moreno L, Canteras M, Gómez J. Multiresistant Pseudomona Aeruginosa nosocomial infections including carbapenems: predictive and prognostic factors. Prospective study 2016 - 2017. Magazine Spain of Chemotherapy 2018 [Accessed 05/13/2021]; 31 (2): 123-130. Available at. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159385/.
[3]	Manuel Paz V, MangwaniMordano S, Martínez Maldonado A, Álvarez Hernández D, Solano Gálvez S, Vázquez López R. Pseudomona Aeruginosa: pathogenicity and antimicrobialresistance in urinaryinfection. Magazine. Chileanof Infectolog 2019 [Accessed 05/13/2021]; 36 (2): 180-89 Available at: https://www.revinf.cl/index.php/revinf/article/view/420.
[4]	Chevaliers S, Bouffatirgues E, Bodillis J, Mallot O, Leusohatier O, Feuilloley MG, Orange N, Duffour A, Cornelis P. Structure, function and regulation of Pseudomona Aeruginosa porins. FEMS Microbiology Magazine. 2017 [Accessed 05/13/2021]; 41 (5): 698-722. Available at: https://pubmed.ncbi.nlm.nih.gov/28981745/.
[5]	Pseudomonas Aeruginosa. National Institute of Occupational Safety and Hygiene 2016 [Internet] [Access 04/14/2021]; Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjFvK3N3eXwAhVDSTABHbp2Dg0QFjAAegQIAhAD&url=https%3A%2F%2Fwww.insst.es%2Fdocuments%2F94886%2F353495%2FPseudomonas%2Baeruginosa%2B2017.pdf%2F7e1ed73b-eca5-4578-a4f7-1c8847e6a799&usg=AOvVaw2g1NCTcDHk3QA9TsLB5W0a.
[6]	Arroyo Ruiz LM. Nursing incidence and action on nosocomial infections in Intensive Care. Npunto Magazine 2020 [Accessed 05/14/2021]; 3 (30): 4-31. Available at: https://www.npunto.es/revista/30/incidencia-y-actuacion-de-enfermeria-sobre-las-infecciones-nosocomiales-en-las-unidades- intensive-care.
[7]	Pérez-Verea L, Olivera-Reyes and Alcalde-Mustelier G. R. Nosocomial Infections and Antimicrobial Resistance in the ICU of Hospital J. Albarrán 2015-2016. International Health Convention. Cuba Health. 2018 [Accessed 5/14/2021]; Available at: https://www.google.com/url?Sa=t&rct=j& q=&esrc=s&source=web&cd=&ved=2ahUKEwiJk_Db3uXwAhVJQzABHWtYDg8QFjAAegQIAxAD&url=http%3A%2Fld%2Fwww.convencionsalph18.convencionsalph20%2Fld%2F%2F2018%2Fpaper%2Fdownload%2F1439%2F885&usg=AOvVaw28Ff6gy5C9K4oH0jMcbWAX.
[8]	Fernández-Verdugo A, Escudero D, Cofiño L, Forcelledo L, Telenti M, García-Prieto E et al. "Epidemiological surveillance for multi-resistant microorganisms in a multipurpose ICU". Spain Magazine of Quimioter 2017 [Accessed 05/14/2021]; 30 (3), 201-206. Available at: https://www.google.com/search? Q=Fern% C3% A1ndez-Verdugo + A, + Escudero + DE, + Cofi% C3% B1o + L, + Forcelledo + L, + Telenti + M, + Garc% C3% ADa-Prieto + E + et + al. +% E2% 80% 9CVigilance + epidemiol% C3% B3gica + for + microorganisms + multi-resistant + in + one + ICU + polyvalent% E2% 80% 9D. + Rev. + Esp + Quimioter + 2017 +% 5BAccess + 14/05/2021% 5D% 3B + 30 (3), + 201-206 &sa=X &ved=2ahUKEwjX8ouQ3-XwAhWSsDEKHWpbBwwQ7xYoAHoECA.
[9]	Leralta-González C. “Nosocomial Infections. Importance of Pseudomona Aeruginosa”. Doctoral Thesis. Complutense University, 2017. [Accessed 05/14/2021]
[10]	Castro C. Advances by the CSIC against one of the bacteria that causes the most infections in hospitals. El Independiente 2018 [Internet] [Access 14/05/2021] Available at: https://www.elindependiente.com/vida-sana/2018/04/09/csic-resistencia-antibioticos-bacteria-agresiva/.
[11]	Ruiz Roldan L. Antimicrobial resistance and virulence in non-clinical strains of Pseudomona Aeruginosa. Doctoral Thesis. Universidad de la Roja 2018 [Internet] [Access 21/04/2021] Available at: https://www.google.com/url? Sa=t &rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiE5Y2y4OXwAhXqRTABHR8EBg0QFjAAegQIAhAD=https%3 &url%2F%2Fdialnet.unirioja.es%2Fdescarga%2Ftesis%2F184761.pdf&usg=AOvVaw24Kpva4BxOI_B9Va7nkcWo.
[12]	World Medical Association. Declaration of Helsinki. Ethical principles for medical research on human beings. Korea: AMM Representation; [Internet]. 2008 [accessed 06/12/2020]. Available at: http://bvs.sld.cu/revistas/recursos/helsinki.pdf.
[13]	Asencio Martin MJ, Hernández Bernal M, Yus Teruel S, Minville A. Infections in critical patients. Medicine Magazine 2018 [Accessed 05/15/2021]; 12 (52): 3085-96. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7143597/.
[14]	Edman-Waller J, Ljungstrom L, Jacobson G, Andersson R, Werner M. Systemic symptoms predict presence or development of severe sepsis and septic shock. Infect Dis. 2016 [Accessed 04/12/2021]; 48 (3): 209-14. Available at: https://pubmed.ncbi.nlm.nih.gov/26492354/.
[15]	Oliver A. Epidemiology and mechanisms of resistance to carbapenems in Pseudomona Aeruginosa: role of high-risk clones in multidrug resistance. Infectious Diseases and Clinical Microbiol Magazine 2017 [Accessed 04/21/2021]; 35 (3): 137-138. Available at: https://medes.com/publication/119278.
[16]	Callejas Díaz A. Impact of Pseudomonas Aeruginosa bacteremia in a tertiary level hospital. Mortality and prognostic factors, resource consumption and evolution over time from the microbiological point of view. Thesis. 2016. [Internet] Autonomous University of Madrid [Access 04/12/2021] Available at: https://dialnet.unirioja.es/servlet/tesis?codigo=59606.
[17]	Pérez Morales L, Barletta del Castillo JM, Quintana Hernández H, Reyes Rodríguez I, Otero Espino N. Clinical, epidemiological and microbiological study of patients with pneumonia associated with mechanical ventilation admitted to intensive care wards. Rev. Elect of Medical Sciences of Cienfuegos 2012 [Accessed 05/15/2021]; 10 (4): 1-8. Available at: http://scielo.sld.cu/scielo.php?Script=sci_arttext&pid=S1727-897X2012000400001.
[18]	Miranda Pedroso R. Pneumonia associated with mechanical ventilation. Med Intens and Emerg Cuban Magazine 2019 [Accessed 04/10/2021]; 18 (3): 592. Available at: http://www.revmie.sld.cu/index.php/mie/article/view/592.
[19]	Noriega Campos E, FernándezDreke RM. Incidence and causes of sepsis in a surgical intensive care unit. Cuban Rev of Hygiene and Epidemiology. 2020 [Accessed 11/11/2020]; 57: e 727.Available at: http://www.revepidemiologia.sld.cu/index.php/hie/article/view/727.
[20]	Group of researchers from the Project for the Reduction of Nosocomial Infections in Intensive Care Units (DINUCI Project) Rev. Investig Medicoquir 2021 [Access 16/05/2021]; 13. Supplement.
[21]	Sánchez Rebellón D. Parra Morales T, Kintero Guerrero K, Méndez Fandiño R. Perspective on the microbiological profile of pneumonia associated with mechanical ventilation in highly complex hospitals in Latin America. Horiz Med Magazine 2015 [Accessed 04/21/2021]; 15 (2): 56-65. Available at: http://www.scielo.org.pe/scielo.php?Script=sci_arttext&pid=S1727-558X2015000200009.
[22]	Amusquivar Colque L. COVID-19 and the potential impact on antibiotic resistance Thesis Universidad de San Pablo. 2020 [Internet] [Access 04/16/2021] Available at: https://doi.org/10.1093/jac/dkaa326.
[23]	Nebreda Mayoral T, Miguel Gómez MA, March Rosselló GA, Puentes Fuertes L, Cantón Benito E, MartínezGarcía AM, Muñoz Marin AB, Orduña Domingo A. Bacterial / fungal infection in COVID-19 patients admitted to a tertiary hospital from Castilla León, Spain. Magazine Infectious Diseases and Clinical Microbiology 2021 [Accessed 05/19/2021]; Available at: https://doi.org/10.1016/j.eimc.2020.11.003/.
[24]	Aguilera Calzadilla Y, Díaz Morales Y, Ortiz Díaz L, González Martínez O, Lovelle Enríquez O, Sánchez Álvarez M. Bacterial infections associated with COVID-19 in patients in an intensive care unit. Med Militar Cuban Magazine 2020 [Accessed 04/12/2021]; 49 (3): e0200793 Available at: http://www.revmedmilitar.sld.cu/index.php/mil/article/view/793.
[25]	Langford BJ, So M, Raybardhan S, Leung V, Westwood D, Mac Fadden DR, Soucy J-PR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta- analysis. Clinical Microbiology and Infection 2020 [Internet] [Accessed 04/16/2021] Available at: https://pubmed.ncbi.nlm.nih.gov/32711058/.
[26]	Beović, B., Doušak, M., Ferreira-Coimbra, J., Nadrah, K., Rubulotta, F., Belliato, M., Berger Estilita, J., Ayoade, F., Rello, J. and Erdem, H. Antibiotic use in patients with COVID-19: a 'snapshot' Infectious Diseases International Research Initiative (ID-IRI) survey. Journal of Antimicrobial Chemotherapy 2020 [Internet] [Accessed 05/12/2021] Available at: https://pubmed.ncbi.nlm.nih.gov/32766706/.

Cite This Article

Plain Text BibTeX RIS

APA Style

Evelin Noriega Campos. (2021). Pseudomona Aeruginosa: A Challenge for Intensive Care Units. American Journal of Health Research, 9(5), 112-116. https://doi.org/10.11648/j.ajhr.20210905.11

Copy | Download

ACS Style

Evelin Noriega Campos. Pseudomona Aeruginosa: A Challenge for Intensive Care Units. Am. J. Health Res. 2021, 9(5), 112-116. doi: 10.11648/j.ajhr.20210905.11

Copy | Download

AMA Style

Evelin Noriega Campos. Pseudomona Aeruginosa: A Challenge for Intensive Care Units. Am J Health Res. 2021;9(5):112-116. doi: 10.11648/j.ajhr.20210905.11

Copy | Download

@article{10.11648/j.ajhr.20210905.11,
  author = {Evelin Noriega Campos},
  title = {Pseudomona Aeruginosa: A Challenge for Intensive Care Units},
  journal = {American Journal of Health Research},
  volume = {9},
  number = {5},
  pages = {112-116},
  doi = {10.11648/j.ajhr.20210905.11},
  url = {https://doi.org/10.11648/j.ajhr.20210905.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20210905.11},
  abstract = {Introduction: Pseudomonas Aeruginosa is one of the main gram-negative germs that cause nosocomial infections, very frequent in intensive care units, with an increase in antimicrobial resistance in recent years. The World Health Organization (WHO) expressed the existence of a problem that threatens modern medicine: bacterial resistance together with infections associated with healthcare. Objectives: to carry out a bibliographic review on the incidence of Pseudomonas Aeruginosa in intensive care units and its presence as a causal agent of coinfection in patients with COVID-19. Methods: a search of articles was carried out in internet search engines in Spanish and English such as: Pubmed, Medline, Academic Google, Dialnet; of articles published in the last ten years in Spanish or English, the term Pseudomonas Aeruginosa was used as the only descriptor in intensive care units, COVID-19. Conclusions: in almost all patients with nosocomial infections, mainly those with pneumonia associated with mechanical ventilation, the common denominator is the isolation of Pseudomona Aeruginosa in at least one of the cultures performed. This situation is maintained as a problem to be solved that shows greater complexity in the context of the current pandemic. Is necessary to establish new cross infection control measures and analyze other therapeutic alternatives if one takes into account that resistance has been increasing in recent years.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Pseudomona Aeruginosa: A Challenge for Intensive Care Units
AU  - Evelin Noriega Campos
Y1  - 2021/09/04
PY  - 2021
N1  - https://doi.org/10.11648/j.ajhr.20210905.11
DO  - 10.11648/j.ajhr.20210905.11
T2  - American Journal of Health Research
JF  - American Journal of Health Research
JO  - American Journal of Health Research
SP  - 112
EP  - 116
PB  - Science Publishing Group
SN  - 2330-8796
UR  - https://doi.org/10.11648/j.ajhr.20210905.11
AB  - Introduction: Pseudomonas Aeruginosa is one of the main gram-negative germs that cause nosocomial infections, very frequent in intensive care units, with an increase in antimicrobial resistance in recent years. The World Health Organization (WHO) expressed the existence of a problem that threatens modern medicine: bacterial resistance together with infections associated with healthcare. Objectives: to carry out a bibliographic review on the incidence of Pseudomonas Aeruginosa in intensive care units and its presence as a causal agent of coinfection in patients with COVID-19. Methods: a search of articles was carried out in internet search engines in Spanish and English such as: Pubmed, Medline, Academic Google, Dialnet; of articles published in the last ten years in Spanish or English, the term Pseudomonas Aeruginosa was used as the only descriptor in intensive care units, COVID-19. Conclusions: in almost all patients with nosocomial infections, mainly those with pneumonia associated with mechanical ventilation, the common denominator is the isolation of Pseudomona Aeruginosa in at least one of the cultures performed. This situation is maintained as a problem to be solved that shows greater complexity in the context of the current pandemic. Is necessary to establish new cross infection control measures and analyze other therapeutic alternatives if one takes into account that resistance has been increasing in recent years.
VL  - 9
IS  - 5
ER  -

Copy | Download

Author Information

Evelin Noriega Campos

National Center for Minimal Surgery, University of Medical Sciences, Havana, Cuba

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Evelin Noriega Campos. (2021). Pseudomona Aeruginosa: A Challenge for Intensive Care Units. American Journal of Health Research, 9(5), 112-116. https://doi.org/10.11648/j.ajhr.20210905.11

Copy | Download

ACS Style

Evelin Noriega Campos. Pseudomona Aeruginosa: A Challenge for Intensive Care Units. Am. J. Health Res. 2021, 9(5), 112-116. doi: 10.11648/j.ajhr.20210905.11

Copy | Download

AMA Style

Evelin Noriega Campos. Pseudomona Aeruginosa: A Challenge for Intensive Care Units. Am J Health Res. 2021;9(5):112-116. doi: 10.11648/j.ajhr.20210905.11

Copy | Download

@article{10.11648/j.ajhr.20210905.11,
  author = {Evelin Noriega Campos},
  title = {Pseudomona Aeruginosa: A Challenge for Intensive Care Units},
  journal = {American Journal of Health Research},
  volume = {9},
  number = {5},
  pages = {112-116},
  doi = {10.11648/j.ajhr.20210905.11},
  url = {https://doi.org/10.11648/j.ajhr.20210905.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20210905.11},
  abstract = {Introduction: Pseudomonas Aeruginosa is one of the main gram-negative germs that cause nosocomial infections, very frequent in intensive care units, with an increase in antimicrobial resistance in recent years. The World Health Organization (WHO) expressed the existence of a problem that threatens modern medicine: bacterial resistance together with infections associated with healthcare. Objectives: to carry out a bibliographic review on the incidence of Pseudomonas Aeruginosa in intensive care units and its presence as a causal agent of coinfection in patients with COVID-19. Methods: a search of articles was carried out in internet search engines in Spanish and English such as: Pubmed, Medline, Academic Google, Dialnet; of articles published in the last ten years in Spanish or English, the term Pseudomonas Aeruginosa was used as the only descriptor in intensive care units, COVID-19. Conclusions: in almost all patients with nosocomial infections, mainly those with pneumonia associated with mechanical ventilation, the common denominator is the isolation of Pseudomona Aeruginosa in at least one of the cultures performed. This situation is maintained as a problem to be solved that shows greater complexity in the context of the current pandemic. Is necessary to establish new cross infection control measures and analyze other therapeutic alternatives if one takes into account that resistance has been increasing in recent years.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Pseudomona Aeruginosa: A Challenge for Intensive Care Units
AU  - Evelin Noriega Campos
Y1  - 2021/09/04
PY  - 2021
N1  - https://doi.org/10.11648/j.ajhr.20210905.11
DO  - 10.11648/j.ajhr.20210905.11
T2  - American Journal of Health Research
JF  - American Journal of Health Research
JO  - American Journal of Health Research
SP  - 112
EP  - 116
PB  - Science Publishing Group
SN  - 2330-8796
UR  - https://doi.org/10.11648/j.ajhr.20210905.11
AB  - Introduction: Pseudomonas Aeruginosa is one of the main gram-negative germs that cause nosocomial infections, very frequent in intensive care units, with an increase in antimicrobial resistance in recent years. The World Health Organization (WHO) expressed the existence of a problem that threatens modern medicine: bacterial resistance together with infections associated with healthcare. Objectives: to carry out a bibliographic review on the incidence of Pseudomonas Aeruginosa in intensive care units and its presence as a causal agent of coinfection in patients with COVID-19. Methods: a search of articles was carried out in internet search engines in Spanish and English such as: Pubmed, Medline, Academic Google, Dialnet; of articles published in the last ten years in Spanish or English, the term Pseudomonas Aeruginosa was used as the only descriptor in intensive care units, COVID-19. Conclusions: in almost all patients with nosocomial infections, mainly those with pneumonia associated with mechanical ventilation, the common denominator is the isolation of Pseudomona Aeruginosa in at least one of the cultures performed. This situation is maintained as a problem to be solved that shows greater complexity in the context of the current pandemic. Is necessary to establish new cross infection control measures and analyze other therapeutic alternatives if one takes into account that resistance has been increasing in recent years.
VL  - 9
IS  - 5
ER  -

Copy | Download